HomeFATE • NASDAQ
add
Fate Therapeutics Inc
Previous close
$0.93
Day range
$0.87 - $0.93
Year range
$0.87 - $8.27
Market cap
104.78M USD
Avg Volume
2.58M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 1.86M | 10.98% |
Operating expense | 31.73M | -4.83% |
Net income | -52.15M | -18.20% |
Net profit margin | -2.80K | -6.51% |
Earnings per share | -0.44 | 2.22% |
EBITDA | -42.20M | 2.30% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 279.07M | -11.46% |
Total assets | 440.69M | -12.94% |
Total liabilities | 121.97M | -11.49% |
Total equity | 318.73M | — |
Shares outstanding | 114.60M | — |
Price to book | 0.33 | — |
Return on assets | -25.12% | — |
Return on capital | -27.16% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -52.15M | -18.20% |
Cash from operations | -27.80M | 24.12% |
Cash from investing | 22.82M | -49.69% |
Cash from financing | 3.13M | 1,838.89% |
Net change in cash | -1.85M | -121.71% |
Free cash flow | -14.44M | 28.62% |
About
Founded
2007
Website
Employees
181
